LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ZGN
Ermenegildo Zegna N.V.
There isn't enough reported data to score ZGN yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ZGN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
ZGN's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ZGN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 23x | $9.68 | -29% |
| Fair | 26x | $10.98 | -19% |
| Current | 41x | $13.57 | — |
| Expensive | 54x | $22.47 | +66% |
Historical ranges are pointers, not guarantees.
ZGN's PE is 41x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ZGN Forward outlook
There aren't enough analyst estimates for ZGN to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ZGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.42 | +27% |
ZGN and LCID do not have enough comparable growth data to identify a winner.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ZGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.1B | +7.9% |
| Q4 2025 | $1.1B | +0.3% |
| Q2 2025 | $1B | -3.4% |
| Q4 2024 | $1.1B | -1.5% |
| Q2 2024 | $1.1B | +6.3% |
| Q4 2023 | $1.1B | +31% |
| Q2 2023 | $1B | +24% |
| Q4 2022 | $848.6M | +12% |
ZGN has the edge over LCID in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.5% | -0.1 points |
| Q4 2025 | 7.9% | -1.3 points |
| Q2 2025 | 6.6% | -6.3 points |
| Q4 2024 | 9.5% | +0.3 points |
| Q2 2024 | 7.6% | -3.5 points |
| Q4 2023 | 9.2% | +31 points |
| Q2 2023 | 13% | +4.4 points |
| Q4 2022 | 9.2% | +1.1 points |
ZGN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ZGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $122.7M | +73% |
| Q4 2025 | $212.6M | +80% |
| Q2 2025 | $70.7M | -12% |
| Q4 2024 | $118.3M | -22% |
| Q2 2024 | $80.6M | -11% |
| Q4 2023 | $151.6M | +61% |
| Q2 2023 | $91M | +552% |
| Q4 2022 | $94.1M | -32% |
ZGN generated $524M in free cash flow over the past year, up 26% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ZGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +8.8M shares |
| 1 year | +6.7% | +17M shares |
| 3 years | +12% | +27.9M shares |
ZGN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | $505.5M |
| Q2 2021 | $426,586 |
| Q4 2020 | $1M |
| Q2 2020 | — |
| Q4 2019 | $52,212 |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ZGN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 0.1x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
| Q2 2024 | 0.4x | Very low |
| Q4 2023 | 0.3x | Very low |
ZGN's net debt is less than a year of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ZGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 54.9 | Neutral |
ZGN's weekly RSI is 55 (neutral) and its Stochastic is 55 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ZGN PE vs Consumer Cyclical Sector
| Metric | ZGN | Sector median | Relative |
|---|---|---|---|
| PE | 41x | 18x | 128% above |
| PE % | 78 | 55 | 23 pts above |
ZGN is trading at 41x earnings, a 128% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ZGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.2 | 3% above |
| 20 week MA | $13.4 | 1.3% above |
| 50 week MA | $12.2 | 11% above |
| 100 week MA | $10.4 | 30% above |
| 200 week MA | $11.2 | 21% above |
ZGN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
ZGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $12.0 | $12.0 | 0% |
| 2022 | $12.0 | $10.0 | -17% |
| 2023 | $10.0 | $11.6 | +16% |
| 2024 | $11.6 | $8.35 | -28% |
| 2025 | $8.35 | $10.5 | +25% |
| 2026 YTD | $10.5 | $13.6 | +30% |
ZGN has the edge over LCID on returns for 2026, with the stronger performance.